XENE Financials
Xenon Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$60.02
Market Cap
$2.55B
P/E Ratio
-19.9
EPS
$-3.01
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-234.33M
EPS (Diluted)
$-3.01
Balance Sheet Highlights
Total Assets
$798.14M
Total Liabilities
$43.24M
Shareholders Equity
-
Cash & Equivalents
$142.71M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-181.39M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-3181.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is XENE revenue?
View XENE's income statement for detailed revenue data.
Is XENE profitable?
XENE reported a loss of $234.33M in the most recent quarter. The net profit margin is -3181.1%.
What is XENE market cap?
XENE has a market capitalization of $2.55B, making it a mid-cap stock.
Does XENE have debt?
View XENE's balance sheet for debt information.
What is XENE cash flow?
Cash flow data is available in the full financial statements.